| Serial Number | 79237279 |
| Word Mark | CEIROX |
| Filing Date | Wednesday, April 4, 2018 |
| Status | 709 - CANCELLED - SECTION 71 |
| Status Date | Friday, July 10, 2026 |
| Registration Number | 5940525 |
| Registration Date | Tuesday, December 24, 2019 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, October 8, 2019 |
| Goods and Services | Pharmaceutical preparations in the nature of anti-inflammatory agents and anti-infectives, and for the treatment of disorders of the endocrine system, skin disorders, coughs, colds, influenza, headaches, stomach and digestive disorders, muscular and/or rheumatic disorders, immune system disorders and related diseases, allergic reactions, metabolic disorders, ocular disorders, and for use in oncology; pharmaceuticals for the treatment of cancer, viral infections, neoplastic, metabolic, autoimmune or inflammatory disorders; chemico-pharmaceutical preparations, namely, for the prevention and treatment of cancer, viral infections, neoplastic, metabolic, autoimmune, inflammatory, dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, hormonal and diabetic disorders; diagnostic preparations, chemical diagnostic and treatment preparations and chemical reagents for medical, pharmaceutical and veterinary purposes; biomedical products, namely, mixed biological preparations for the prevention and treatment of skin diseases, immune system disorders, cancer; living organs and tissues for surgical use; biological implants, namely, biological skin tissues; pharmaceutical implants, namely, implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for the prevention and treatment of cancer, viral infections, neoplastic, metabolic, autoimmune, inflammatory, dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, hormonal and diabetic disorders; skin grafts; all of the foregoing also available in time release formula |
| Goods and Services | Scientific and technological services, namely, research and related design services in the field of medical technology, laboratory technology; research in the fields of pharmacy, medicine, biology, chemistry and laboratory technology; development, programming and implementation of software; IT consultancy, advisory and information services; creation of programs for data processing using information stored in databases; scientific analyses, namely, medical and pharmaceutical analyses; research services of a medical, biological, chemical laboratory; consulting, evaluation, research, testing, monitoring in the field of biology, bacteriology, chemistry for scientific research purposes; medical and pharmaceutical research services in the field of radiology, chemotherapy, hormone therapy, cell therapy, skin regeneration, regeneration of the joints; clinical research in the field of radiology, chemotherapy, hormone therapy, cell therapy, skin regeneration, regeneration of the joints; pharmaceutical research and development services; research and development in the field of biotechnology |
| Goods and Services | Surgical, medical, dental and veterinary apparatus and instruments, namely, artificial organs and implants comprised of artificial materials; artificial skin for surgical purposes; surgical and wound care equipment, namely, drainage apparatus, suction apparatus, medical devices for closing wounds; diagnostic, examination and monitoring equipment, namely, blood pressure and diabetic diagnostic medical devices, flow cytometers for medical diagnostic uses, respiratory equipment and monitors therefor, patient monitors for critical care and anesthesia; diagnostic apparatus for medical purposes, namely, ultrasonic medical diagnostic apparatus, medical diagnostic apparatus for testing DNA and RNA samples; syringes for medical purposes; surgical instruments for skin surgery; all of the aforesaid goods being wholly or partly for administering medicine for the delayed, controlled or immediate release of the agents of pharmaceutical preparations |
| Goods and Services | Medical services; medical clinic services; provision of medical information through websites, digital media and databases; providing medical information to doctors, patients and care givers via the Internet, digital media and databases; provision of medical services relating to the use of medical apparatus, instruments and devices; providing health information; providing medical information; medical diagnostic tests, monitoring and reporting services; medical services, namely, providing medical information relating to disease symptoms, medical experiences, support possibilities via an interactive platform for patients and care-givers; collection and preservation of biological tissue, blood and cells; medical-diagnostic services |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, July 10, 2026 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, July 10, 2026 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, July 10, 2026 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, July 10, 2026 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | CeiROx Life Sciences SA |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 09 - Joint Stock Company |
| Address | CH |
| Party Name | CeiROx Life Sciences SA |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 09 - Joint Stock Company |
| Address | CH |
| Party Name | CeiROx Life Sciences SA |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 09 - Joint Stock Company |
| Address | CH |
| Event Date | Event Description |
| Thursday, July 26, 2018 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, July 27, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, July 27, 2018 | ASSIGNED TO EXAMINER |
| Tuesday, July 31, 2018 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, July 31, 2018 | NON-FINAL ACTION WRITTEN |
| Wednesday, August 1, 2018 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, August 14, 2018 | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW |
| Wednesday, August 15, 2018 | NON-FINAL ACTION WRITTEN |
| Thursday, August 16, 2018 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, August 23, 2018 | REFUSAL PROCESSED BY MPU |
| Thursday, August 23, 2018 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, September 8, 2018 | REFUSAL PROCESSED BY IB |
| Monday, February 18, 2019 | FAX RECEIVED |
| Monday, February 25, 2019 | ASSIGNED TO LIE |
| Monday, February 25, 2019 | PAPER RECEIVED |
| Wednesday, February 27, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, February 27, 2019 | AMENDMENT FROM APPLICANT ENTERED |
| Tuesday, March 26, 2019 | FINAL REFUSAL WRITTEN |
| Wednesday, March 27, 2019 | FINAL REFUSAL MAILED |
| Wednesday, July 31, 2019 | FAX RECEIVED |
| Monday, August 5, 2019 | PAPER RECEIVED |
| Tuesday, August 13, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, August 13, 2019 | AMENDMENT FROM APPLICANT ENTERED |
| Friday, August 30, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, September 18, 2019 | NOTICE OF PUBLICATION |
| Wednesday, September 18, 2019 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, September 18, 2019 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Friday, October 4, 2019 | NOTIFICATION PROCESSED BY IB |
| Tuesday, October 8, 2019 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 24, 2019 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, March 24, 2020 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Monday, April 6, 2020 | FINAL DISPOSITION PROCESSED |
| Monday, April 6, 2020 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, April 24, 2020 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Friday, July 10, 2026 | CANCELLED SECTION 71 |